Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis

CompletedOBSERVATIONAL
Enrollment

722

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

December 31, 2023

Conditions
TUBERCULOSIS, PULMONARY
Interventions
DIAGNOSTIC_TEST

ISIT-TB prototype

Diagnostic assay able to identify active tuberculosis using a patient blood sample processed on an automatized system within an hour

Trial Locations (1)

7700

University of Cape Town Lung Institute, Cape Town

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioMérieux

INDUSTRY

NCT04995406 - Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis | Biotech Hunter | Biotech Hunter